Answers are grounded in this paper and cite their sources.
T he incidence of coronavirus disease (COVID-19), caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has spread rapidly globally; as of March 29, 2020, 670,000 cases had been confirmed worldwide (1). COVID-19 is typically a pulmonary infection that can range from mild illness to acute respiratory distress syndrome and multiple organ failure; however, other symptoms such as myalgias and anorexia have been noted (2). Although many ongoing studies are investigating measurement of proinflammatory cytokines and other biomarkers as a way to prognosticate infection severity, we investigated use of 2 easily obtained predictors: lymphopenia and leukocytosis (3).
No takes yet. Share an insight, caveat, or question.
Huang et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: